HESA Committee Meeting
Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
Notice of meeting Amended
Standing Committee on Health (HESA)
42nd Parliament, 1st Session
Meeting No. 66
Wednesday, September 13, 2017, 8:30 a.m. to 6:00 p.m.
Televised
8:30 a.m. to 10:30 a.m.
Panel on Household Cultivation of Plants
Witnesses
Anandia Labs
• Jonathan Page, Chief Executive Officer
As an individual
• John Conroy, Barrister
Canadian Federation of Apartment Associations
• John Dickie, President
10:45 a.m. to 12:45 p.m.
Panel on the Age for Legal Possession and Impact on Young Canadians
Witnesses
Canadian Drug Policy Coalition
• Scott Bernstein, Senior Policy Analyst (by videoconference: Vancouver, British Columbia)
Canadian Public Health Association
• Ian Culbert, Executive Director
Canadian Paediatric Society
• Christina Grant, Member of the Adolescent Health Committee
Educators for Sensible Drug Policy
• Judith Renaud, Executive Director
• Paul Renaud, Communications Director
Portage
• Peter A. Howlett, President
• Peter Vamos, Executive Director
1:45 p.m. to 3:45 p.m.
Panel on the Age for Legal Possession and Impact on Young Canadians
Witnesses
Canadian Centre on Substance Use and Addiction
• Amy Porath, Director, Research and Policy
Drug Free Kids Canada
• Marc Paris, Executive Director
• William J. Barakett, Member, DFK Canada Advisory Council
Institut national de santé publique du Québec
• Maude Chapados, Scientific Advisor
• François Gagnon, Scientific Advisor
4:00 p.m. to 6:00 p.m.
Panel on Prevention, Treatment, and Low Risk Use
WitnessesAmended
As an individual
• Gabor Maté, Gabor Maté Consulting Ltd. (by videoconference: Vancouver, British Columbia)
Centre for Addiction and Mental Health
• Benedikt Fischer, Senior Scientist, Institute for Mental Health Policy Research
• Bernard Le Foll, Medical Head, Addiction Medicine Service, Acute Care Program (by videoconference: Toronto, Ontario)
City of Toronto
• Eileen de Villa, Medical Officer of Health, Toronto Public Health
As an individual
• Sharon Levy, Director, Adolescent Substance Abuse Program, Boston Children's Hospital (by videoconference: New York, New York)
Amended Section
Ontario Public Health Association
• Michelle Suarly, Chair, Cannabis Task Group
• Elena Hasheminejad, Member, Cannabis Task Group
Clerk of the Committee
David Gagnon (613-995-4108)
2017/09/11 6:47 p.m.